10th ICID : Satellite Symposia

10th ICID

Schedule
Congress Committees
Commercial Exhibition
ISID Business Meeting
Awards
Scientific Program
   · Plenary Lectures
   · Symposia
   · Satellite Symposia
   · Poster Sessions
   · Meet-the-Experts
   · Workshops
   · Acknowledgements
Abstract Guidelines
Registration
Hotels
   · List of Hotels
   · Map of Hotels
General Information
Tours

Shortcut to Online System

Abstract Submission
Conference Registration
Hotel and Tour Reservation

Shortcut to PDF Forms

Abstract Submission
Conference Registration
Hotel and Tour Reservation

10th ICID

Satellite Symposia (as per February 5, 2002)

Hepatitis Disease Management — Integrating Prevention, Diagnostics and Therapeutics
(Pre-Congress Satellite Symposium sponsored by GlaxoSmithKline)
Monday, March 11, 2002, 13:00 to 16:00hrs, Sophia & Olivia Rooms

Hepatitis Disease Management: A Comprehensive Prevention, Diagnosis and Treatment Program — Past, Present, and Future
Francis André (BELGIUM)
Therapeutic Advances in Chronic Hepatitis B
Ching Lung Lai (CHINA)
Review of Economic Benefits of Treating Chronic Hepatitis B with Lamivudine
Larry Lacey (UNITED KINGDOM)
Prevention of Viral Hepatitis in Hong Kong — Next Steps?
Betty Young (CHINA)
Hepatitis Disease Management Programs in Malaysia
Nor Shahidah Khairullah (MALAYSIA)
The Importance and Benefits of Hepatitis A Prevention in Chronic Liver Disease (CLD) Patients
Graham Cooksley (AUSTRALIA)

Innovative Strategies in an Evolving World of Gram-Positive Pathogens
(Dinner Satellite Symposium sponsored by Pharmacia)
Tuesday, March 12, 2002, 18:00 to 22:00hrs, Canning Room

Bacterial Pathogenicity– Why are Some Strains More Successful Than Others?
David Livermore (UNITED KINGDOM)
Strategies for Infections in the Intensive Care Unit
Pramod M. Shah (GERMANY)
Post-Surgical Infections
Joseph S. Solomkin (USA)
Linezolid Versus Standard Therapy – Are New Antibiotics Better than Glycopeptides?
Mark H. Wilcox (UNITED KINGDOM)
Update on Linezolid Safety Profile
Sue K. Cammarata (USA)

Bacterial Eradication – Rationale for Antimicrobial Assessment
(Dinner Satellite Symposium sponsored by GlaxoSmithKline)
Tuesday, March 12, 2002, 18:00 to 22:00hrs, Olivia Room

Welcome and Introduction: Goals of Antimicrobial Therapy
Jae-Hoon Song (REPUBLIC OF KOREA)
Why Do We Need to Eradicate Pathogens in Respiratory Tract Infection?
Javier Garau (SPAIN)
How Can We Predict Bacterial Eradication?
Michael R. Jacobs (USA)
Achieving Bacterial Eradication
Ron Dagan (ISRAEL)
Implications for Antimicrobial Prescribing
Keith Klugman (USA)

Do Your Antimicrobial Options Meet Your Needs? — Using the Best in Class for Appropriate Empiric Coverage
(Dinner Satellite Symposium sponsored by Bayer Ag)
Wednesday, March 13, 2002, 18:00 to 20:00hrs, Olivia Room

Can We Prevent the Hospitalization of Pneumonia Patients?
Keith Klugman (South Africa)
Emerging Resistance Among Respiratory Pathogens
Jay Song (REPUBLIC OF KOREA)
Pharmacokinetic Predictors of Clinical Outcome
John Turnidge (AUSTRALIA)
Moxifloxacin IV — A Novel Parenteral Therapy for CAP
Tom File (USA)
Providing Clinical Confidence for Today's Infections
Ron Grossman (CANADA)

ProMED-mail | about us | membership | programs | publications
IMED | 14th ICID | site map | home

1330 Beacon Street, Suite 228, Brookline MA 02446 · USA
Phone: (617) 277-0551 · Fax: (617) 278-9113 · info@isid.org
Contact Us

©2001-2010 International Society for Infectious Diseases
All Rights Reserved.
Read our privacy guidelines.
Use of this web site and related services is governed by the Terms of Service.